Chlamydia suis and Chlamydia trachomatis induce multifunctional CD4 T cells in pigs

Area of Science:

• Immunology
• Microbiology
• Veterinary Medicine

Background:

• Chlamydia trachomatis is a leading bacterial STI globally, necessitating vaccine development.
• Pigs serve as a relevant animal model for studying chlamydial infections and vaccine efficacy.
• Chlamydia suis naturally infects pigs and possesses zoonotic potential, making it important for comparative studies.

Purpose of the Study:

• To investigate the T-cell-mediated immune response to genital infections with Chlamydia trachomatis and Chlamydia suis in pigs.
• To evaluate the pig as an animal model for chlamydial vaccine development.
• To assess potential cross-protection between C. trachomatis and C. suis infections.

Main Methods:

• Genital inoculation of pigs with C. suis and C. trachomatis.
• Monitoring infection duration and pathological changes.
• Analysis of humoral and T-cell-mediated immune responses, including cytokine production (IFN-γ, TNF-α, IL-17) and T-cell subsets (CD4+).
• In vitro re-stimulation assays to assess homologous and heterologous responses.

Main Results:

• Both C. suis and C. trachomatis established persistent genital infections in pigs, causing significant pathology.
• Humoral immune responses, including neutralizing antibodies, were primarily observed against C. suis.
• T-cell-mediated immune responses, dominated by IFN-γ/TNF-α producing CD4+ T-helper 1 cells, were initiated by day 7 post-inoculation for both species.
• IL-17 producing CD4+ T cells were rare or absent.
• Immune responses were triggered by both homologous and heterologous re-stimulation, indicating possible cross-protection.

Conclusions:

• Pigs provide a robust model for studying genital chlamydial infections and host-pathogen interactions.
• The pig model facilitates the assessment of T-cell-mediated immunity relevant to C. trachomatis vaccine development.
• Evidence of cross-protection suggests potential for broad-spectrum chlamydial vaccines.